EUVIMEDEUVIMED entdecken
Crossref

Therapeutic Evaluation of Reserpine against Biofilm-forming Staphylococcus aureus of Bovine Mastitis in a Murine Model

Jayant P. Hole, Kalyani Putty, Shivajyothi Jemmigumpula, Krishna Satya Alapati

Indian Journal of Animal Research · 08.06.2026 · (Of)

DOI: 10.18805/ijar.b-5802 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Indian Journal of Animal Research, online erschienen am 08.06.2026. Verfasst von Jayant P. Hole und 3 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Within the mammary gland, S. aureus establishes biofilm communities that contribute to treatment failure, recurrence and increased antimicrobial use in bovine mastitis. Strategies that disrupt biofilm-associated survival mechanisms may therefore improve therapeutic outcomes while supporting antimicrobial stewardship.

Methods

In this study, we integrated robust computational screening of seventeen biofilm-associated S. aureus proteins implicated in adhesion, extracellular matrix production and transcriptional regulation against selected plant-derived polyphenolic compounds, followed by in vitro and in vivo validation to identify adjunctive therapeutic strategies for mastitis management.

Result

Reserpine emerged as a multi-target candidate, with predicted interactions across key biofilm determinants, including adhesins and regulatory proteins. In vitro, reserpine significantly reduced biofilm biomass (68.6-71.5% inhibition) and decreased viable bacterial counts by greater than 95%, indicating disruption of both biofilm matrix integrity and bacterial persistence. In a murine mastitis model, reserpine monotherapy modestly reduced intramammary bacterial load. However, when combined with ceftiofur, bacterial burden declined by approximately three log units relative to untreated controls, accompanied by reduced inflammatory infiltration and improved preservation of mammary architecture. Targeting intrinsic persistence pathways alongside conventional antibiotic therapy may present a clinically relevant approach for improving therapeutic outcomes in biofilm driven bovine mastitis while reducing reliance on escalating antimicrobial use in dairy systems.

Zitieren

APA

Hole, J. P., Putty, K., Jemmigumpula, S., & Alapati, K. S. (2026). Therapeutic Evaluation of Reserpine against Biofilm-forming Staphylococcus aureus of Bovine Mastitis in a Murine Model. Indian Journal of Animal Research. https://doi.org/10.18805/ijar.b-5802

Vancouver

Hole JP, Putty K, Jemmigumpula S, Alapati KS. Therapeutic Evaluation of Reserpine against Biofilm-forming Staphylococcus aureus of Bovine Mastitis in a Murine Model. Indian Journal of Animal Research. 2026. doi:10.18805/ijar.b-5802

BibTeX
@article{Hole2026,
  author = {Hole, Jayant P. and Putty, Kalyani and Jemmigumpula, Shivajyothi and Alapati, Krishna Satya},
  title = {Therapeutic Evaluation of Reserpine against Biofilm-forming Staphylococcus aureus of Bovine Mastitis in a Murine Model},
  journal = {Indian Journal of Animal Research},
  year = {2026},
  number = {Of},
  doi = {10.18805/ijar.b-5802}
}
Kostenlos starten →